Extended deadline! Nominations are open until July 1, for international candidates. Apply today! Find out more
Thanks again for all of your heartfelt support to Kumamoto from all over the world.
Infant’s tumor regression shows promise for experimental treatment.
“More than any one individual, Dan Hays helped set the standard for the specialty of modern pediatric cancer surgery,”
Please note that the SIOP 2019 Annual Meeting Call for Bids have been closed.
Cancer is the leading disease-related cause of death in children in the United States. Yet pediatric cancer is often left behind when it comes to funding research and developing new drugs.
We aim to link patients, doctors and researchers in the fight against Rare Childhood Brain Tumors.
FOR any child who has cancer, their best bet is to complete treatment in order to be cured.